AI for Bio · Model

xTrimoSCPerturb / scFoundation

BioMap's single-cell foundation model scFoundation and the VCC 2025-winning perturbation entry built on it

Single-cell & perturbationMixedChinaActive中文

Overview

NamexTrimoSCPerturb / scFoundation · aliases: xTrimoSCPerturb, scFoundation, xTrimoscFoundationα, BM_xTVC
Full nameNeither name has an expanded form
Ambiguous names (not auto-linked)xTrimo
FamilyscFoundation is the public foundation model; xTrimoSCPerturb is an unreleased challenge solution built on a modified version
  • scFoundation ·
  • xTrimoSCPerturb · †
OrganizationBioMap, Tsinghua University
Organization typeMixed
CountryChina
Model classSingle-cell FM / perturbation
DomainSingle-cell & perturbation
First release · paper revision
Basis: scFoundation bioRxiv preprint v1 source
Other milestones
  • First public evidence: · bioRxiv preprint v1 source
  • Preprint v1: · bioRxiv preprint v1 source
  • Journal online: · Nature Methods online (registry record; issue dated 2024-08) source
Latest update† partly verified · results
Basis: Official VCC 2025 wrap-up names xTrimoSCPerturb overall first
The organiser published the ranking but no scores, paper or weights; the scFoundation repository had only README edits in 2025-11
Note: The wrap-up's exact day was not retrieved; month-level evidence only source
The most recent sourced event, not a claim that nothing changed since.
StatusActive · Challenge result published within 12 months
OpennessCode: Partly open · Apache-2.0
Weights: Open · Apache-2.0
scFoundation code and weights are public (Apache-2.0); xTrimoSCPerturb has no public repository or weights (checked 2026-11-16)
Benchmarks reported1 counted (board 1)
Wet-lab validationNone recorded
Unverified fields† latest_update, open_status.weights_license, training_data.b_private_licensed, background.funding
As of2026-11-17

What it does

scFoundation is an asymmetric Transformer of about 100M parameters pretrained on expression profiles over about 20k genes; the paper reports downstream tasks such as expression enhancement, drug response, perturbation prediction and cell-type annotation. xTrimoSCPerturb is the team's entry for the Arc Virtual Cell Challenge 2025, described as deep learning plus classical statistical features on a re-pretrained modified scFoundation; unlike general baselines such as scGPT/Geneformer it is a task-specific solution for one challenge.

Benchmarks reported

Every row is one pairing from the survey's relation file; a score belongs to the benchmark page's ranking, where it is shown with metric, eval set, source type and date. 1 of 1 pairings are counted.

BenchmarkRelationEval set / protocolSource typeNote and evidence
24 Virtual Cell Challenge and perturbation benchmarksOfficial leaderboard or results—BoardOverall winner of VCC 2025 per the organizer wrap-up; scores unpublished. · evidence

Other evaluations (outside the 44)

  • Independent perturbation-prediction study (third party evaluation) Third-party: Five foundation models plus two deep models against deliberately simple linear baselines on single and double perturbations; none beat the baseline, scFoundation included
  • scFoundation paper downstream tasks (Own task set) Self-reported: Expression enhancement, drug response, cell-type annotation, gene-module inference and others; author-reported

Developers report: scFoundation leads on many single-cell downstream tasks; xTrimoSCPerturb ranked first overall in VCC 2025 (the latter published by the organiser).

Independent evidence: The organiser confirmed the VCC 2025 ranking but its wrap-up notes pure AI methods did not consistently beat statistical baselines; an independent study found scFoundation did not beat simple linear baselines.

Training data

Group in Figure 7: Public data only.

ClassValueDetail
a. Public databasesYesscFoundation pretraining used over 50 million human single-cell transcriptomes source
b. Private or licensed dataNot disclosed
c. Own wet-lab data used for trainingNoThe H1 perturbation data were produced by Arc and issued to teams for fine-tuning, not generated by the developer source
d. Wet lab used only for validationNo

Wet-lab validation

None. The developers report no wet-lab validation.

Background

  • Organization: BioMap was founded in 2020, is headquartered in Beijing with R&D sites in Suzhou, Hong Kong and Silicon Valley, and builds the xTrimo life-science foundation models; scFoundation also has Tsinghua University authors.
  • Funding: A Series A above $100M in 2021; a 2024 strategic partnership and a further round reported with undisclosed amounts; a 2026-03 media report of a confidential Hong Kong IPO filing, not announced by the company.
  • Products and partnerships: A 2023-10 Sanofi deal for biologics AI modules ($10M upfront, potential milestones over $1B); the protein language model xTrimoPGLM is a sibling.
  • Related models: xTrimoPGLM, scGPT / Geneformer, STATE

Reading notes

  1. The VCC first place is a genuine official result, but the organiser itself notes pure AI methods did not consistently beat statistical baselines.
  2. With no public scores or weights, the rank cannot be turned into comparable accuracy and cannot be reproduced.
  3. Independent evaluations of scFoundation are generally unfavourable, a problem shared across single-cell foundation models.

Caveats

  1. xTrimoSCPerturb is unreleased with no paper; architecture and scores are not public.
  2. The site's Nature Methods 2024-08 is the issue month; online publication was 2024-06-06.
  3. Training data are observational only, with no self-generated perturbation set.

Sources

  1. Official VCC 2025 wrap-up (official site)
  2. scFoundation journal paper (journal)
  3. scFoundation preprint (preprint)
  4. scFoundation repository (repository)
  5. Independent perturbation-prediction evaluation paper (third-party paper)

Corrections

1 correction
FieldWasNowBasisFound
release_milestones.journal_online2024-08 (volume issue)2024-06-06 (published online)source2026-11-16

Part of the AI for Bio benchmarks survey · all 112 models · open in the explorer. Record as of 2026-11-17.